Plastic Vials Market
Plastic Vials Market Forecasts to 2032 - Global Analysis By Material Type (Polyethylene Terephthalate, Polypropylene, Polyethylene and Other Material Types), Closure Type (Screw Caps, Snap-on Caps, Crimp Caps and Other Closure Types), Capacity, Application, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $4.9 BN |
|
Projected Year Value (2032) |
US $7.9 BN |
|
CAGR (2025-2032) |
7.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Plastic Vials Market is accounted for $4.9 billion in 2025 and is expected to reach $7.9 billion by 2032 growing at a CAGR of 7.1% during the forecast period. Plastic vials are small, cylindrical containers typically made from polymers like polyethylene, polypropylene, or PET. They are designed to securely store, transport, and dispense liquids, powders, or small solid samples. Commonly used in pharmaceuticals, laboratories, cosmetics, and diagnostics, plastic vials offer lightweight, shatter-resistant, and cost-effective alternatives to glass vials. They often feature screw caps, snap-on lids, or dropper tops to ensure product safety, prevent contamination, and provide ease of use.
According to data from the Institute of Environmental Management Assessment (IEMA), since the 1950s, approximately 8.3 billion metric tons of plastic have been produced globally.
Market Dynamics:
Driver:
Growing pharmaceutical and biopharmaceutical industry
Increasing demand for vaccines, injectable medications, and diagnostic solutions has accelerated the need for reliable packaging, with plastic vials offering advantages such as chemical resistance, lightweight handling, and cost-effectiveness. Furthermore, the rise in chronic diseases and the aging global population have led to higher consumption of pharmaceuticals, compelling manufacturers to adopt advanced plastic vial solutions to ensure product safety and integrity. This ongoing growth in healthcare infrastructure continues to propel the market forward.
Restraint:
Price fluctuations of raw materials
Price volatility in raw materials, particularly polymers like polypropylene and polyethylene, poses a significant restraint for the plastic vials market. These fluctuations are influenced by changes in crude oil prices, supply chain disruptions, and evolving environmental regulations. Additionally, the increasing emphasis on sustainable packaging and recycling policies can impact raw material availability and cost structures. Such unpredictability in input costs challenges manufacturers' ability to maintain stable pricing and profitability, potentially limiting market expansion.
Opportunity:
Rising healthcare expenditure in emerging markets
Countries in Asia Pacific, Latin America, and Africa invest in expanding healthcare infrastructure and improving access to medical treatments, and the demand for pharmaceutical packaging, including plastic vials, is surging. Moreover, government initiatives to enhance immunization programs and the proliferation of local pharmaceutical manufacturing further amplify this trend. The growing middle-class population and increasing awareness about healthcare drive sustained demand, enabling market players to capitalize on these emerging opportunities.
Threat:
Substitution by glass vials
Glass vials are traditionally preferred for their superior barrier properties, chemical inertness, and established regulatory acceptance, especially for sensitive biologics and high-value drugs. Additionally, concerns over plastic leachables and environmental sustainability may encourage a shift back to glass alternatives. Furthermore, advancements in lightweight and shatter-resistant glass technologies could erode the competitive advantages of plastic vials, compelling manufacturers to innovate and differentiate their product offerings.
Covid-19 Impact:
The Covid-19 pandemic had a profound impact on the plastic vials market, driving unprecedented demand due to the surge in vaccine production and distribution. The urgent need for safe, sterile packaging for vaccines and diagnostic reagents accelerated the adoption of plastic vials, especially in mass immunization campaigns. Additionally, supply chain disruptions and increased use of single-use plastics in healthcare heightened market growth. However, the pandemic also intensified concerns over plastic waste management, prompting renewed focus on sustainable packaging solutions within the industry.
The polypropylene (PP) segment is expected to be the largest during the forecast period
The polypropylene (PP) segment is expected to account for the largest market share during the forecast period. Polypropylene’s dominance stems from its excellent chemical resistance, durability, and cost-effectiveness, making it a preferred material for pharmaceutical packaging. Moreover, PP vials are lightweight, shatterproof, and compatible with a wide range of drugs, including acidic and alkaline formulations. Its recyclability further enhances its appeal amid growing environmental concerns. The versatility and reliability of PP in ensuring product safety and integrity make it the material of choice for manufacturers and end-users alike, sustaining its market leadership.
The screw caps segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the screw caps segment is predicted to witness the highest growth rate. Screw caps are favored for their secure sealing, ease of use, and tamper-evident features, which are crucial for maintaining the sterility and safety of pharmaceutical products. Additionally, their compatibility with automation and mass production processes enhances operational efficiency for manufacturers. The increasing demand for user-friendly, resealable, and contamination-resistant closures in both pharmaceutical and consumer applications is driving the rapid adoption of screw caps, positioning this segment for robust expansion.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share. This dominance is attributed to the region’s vast population, rapid urbanization, and expanding pharmaceutical and healthcare sectors. Countries such as China and India are major contributors, benefiting from robust manufacturing capabilities, cost-effective production, and rising healthcare investments. Furthermore, the growing demand for packaged medicines and the proliferation of local pharmaceutical manufacturers reinforce Asia Pacific’s leadership, making it a pivotal hub for both production and consumption of plastic vials.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is driven by surging healthcare expenditure, increasing adoption of advanced pharmaceutical packaging, and government initiatives promoting local manufacturing. Moreover, the region’s dynamic economic development, burgeoning middle-class population, and heightened focus on healthcare accessibility fuel sustained demand. Innovations in sustainable packaging and the rapid expansion of e-commerce further accelerate market growth.
Key players in the market
Some of the key players in Plastic Vials Market include Amcor, Berry Global, Gerresheimer, AptarGroup, ALPLA Group, Stevanato Group, Schott, SGD Pharma, DWK Life Sciences, Origin Pharma Packaging, West Pharmaceutical Services, Bormioli Pharma, Pacific Vial Manufacturing, O.Berk Company, Comar, Alpha Packaging, Silgan Holdings and Corning.
Key Developments:
In February 2025, Berry Global is introducing a high-quality post-consumer recycled (PCR) plastic polymer for non-contact-sensitive packaging, specifically aimed at the homecare and industrial sectors. Utilising many of the same processes used to produce Berry’s proprietary contact-sensitive PCR, CleanStream® Home and Industrial is suitable for a wide variety of applications with exacting technical specifications. The purity degree of the recycled polymer enables it to be included in greater percentages in all types of packs and in areas which demand a high degree of functional performance, for example trigger spray heads and the lid, ring and handle of paint containers.
In December 2024, Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions.
In October 2023, Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry launches with COP (Cyclic Olefin Polymer) vials a particularly satisfactory solution for the filling and storage of highly sensitive biologics. They are suitable for mRNA active ingredients at -80°C and cryogenic temperatures. Gerresheimer is expanding its RTF portfolio of glass vials in various qualities with a product made of high-quality polymer which combines the best material properties of glass and plastic.
Material Types Covered:
• Polyethylene Terephthalate (PET)
• Polypropylene (PP)
• Polyethylene (PE)
• Other Material Types
Closure Types Covered:
• Screw Caps
• Snap-on Caps
• Crimp Caps
• Other Closure Types
Capacities Covered:
• Small Capacity (Up to 10 ml)
• Medium Capacity (10 ml to 50 ml)
• Large Capacity (Above 50 ml)
Applications Covered:
• Pharmaceutical Packaging
• Diagnostic Reagents & Samples
• Cosmetics & Personal Care
• Chemicals & Laboratory Use
• Other Applications
End Users Covered:
• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
• Diagnostic Laboratories & Research Institutes
• Hospitals & Clinics
• Cosmetic & Personal Care Companies
• Chemical Companies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Plastic Vials Market, By Material Type
5.1 Introduction
5.2 Polyethylene Terephthalate (PET)
5.3 Polypropylene (PP)
5.4 Polyethylene (PE)
5.4.1 High-Density Polyethylene (HDPE)
5.4.2 Low-Density Polyethylene (LDPE)
5.5 Other Material Types
6 Global Plastic Vials Market, By Closure Type
6.1 Introduction
6.2 Screw Caps
6.3 Snap-on Caps
6.4 Crimp Caps
6.5 Other Closure Types
7 Global Plastic Vials Market, By Capacity
7.1 Introduction
7.2 Small Capacity (Up to 10 ml)
7.3 Medium Capacity (10 ml to 50 ml)
7.4 Large Capacity (Above 50 ml)
8 Global Plastic Vials Market, By Application
8.1 Introduction
8.2 Pharmaceutical Packaging
8.3 Diagnostic Reagents & Samples
8.4 Cosmetics & Personal Care
8.5 Chemicals & Laboratory Use
8.6 Other Applications
9 Global Plastic Vials Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biopharmaceutical Companies
9.3 Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
9.4 Diagnostic Laboratories & Research Institutes
9.5 Hospitals & Clinics
9.6 Cosmetic & Personal Care Companies
9.7 Chemical Companies
10 Global Plastic Vials Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Amcor
12.2 Berry Global
12.3 Gerresheimer
12.4 AptarGroup
12.5 ALPLA Group
12.6 Stevanato Group
12.7 Schott
12.8 SGD Pharma
12.9 DWK Life Sciences
12.10 Origin Pharma Packaging
12.11 West Pharmaceutical Services
12.12 Bormioli Pharma
12.13 Pacific Vial Manufacturing
12.14 O.Berk Company
12.15 Comar
12.16 Alpha Packaging
12.17 Silgan Holdings
12.18 Corning
List of Tables
1 Global Plastic Vials Market Outlook, By Region (2024-2032) ($MN)
2 Global Plastic Vials Market Outlook, By Material Type (2024-2032) ($MN)
3 Global Plastic Vials Market Outlook, By Polyethylene Terephthalate (PET) (2024-2032) ($MN)
4 Global Plastic Vials Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
5 Global Plastic Vials Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
6 Global Plastic Vials Market Outlook, By High-Density Polyethylene (HDPE) (2024-2032) ($MN)
7 Global Plastic Vials Market Outlook, By Low-Density Polyethylene (LDPE) (2024-2032) ($MN)
8 Global Plastic Vials Market Outlook, By Other Materials Types (2024-2032) ($MN)
9 Global Plastic Vials Market Outlook, By Closure Type (2024-2032) ($MN)
10 Global Plastic Vials Market Outlook, By Screw Caps (2024-2032) ($MN)
11 Global Plastic Vials Market Outlook, By Snap-on Caps (2024-2032) ($MN)
12 Global Plastic Vials Market Outlook, By Crimp Caps (2024-2032) ($MN)
13 Global Plastic Vials Market Outlook, By Other Closure Types (2024-2032) ($MN)
14 Global Plastic Vials Market Outlook, By Capacity (2024-2032) ($MN)
15 Global Plastic Vials Market Outlook, By Small Capacity (Up to 10 ml) (2024-2032) ($MN)
16 Global Plastic Vials Market Outlook, By Medium Capacity (10 ml to 50 ml) (2024-2032) ($MN)
17 Global Plastic Vials Market Outlook, By Large Capacity (Above 50 ml) (2024-2032) ($MN)
18 Global Plastic Vials Market Outlook, By Application (2024-2032) ($MN)
19 Global Plastic Vials Market Outlook, By Pharmaceutical Packaging (2024-2032) ($MN)
20 Global Plastic Vials Market Outlook, By Diagnostic Reagents & Samples (2024-2032) ($MN)
21 Global Plastic Vials Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
22 Global Plastic Vials Market Outlook, By Chemicals & Laboratory Use (2024-2032) ($MN)
23 Global Plastic Vials Market Outlook, By Other Applications (2024-2032) ($MN)
24 Global Plastic Vials Market Outlook, By End User (2024-2032) ($MN)
25 Global Plastic Vials Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2024-2032) ($MN)
26 Global Plastic Vials Market Outlook, By Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs) (2024-2032) ($MN)
27 Global Plastic Vials Market Outlook, By Diagnostic Laboratories & Research Institutes (2024-2032) ($MN)
28 Global Plastic Vials Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
29 Global Plastic Vials Market Outlook, By Cosmetic & Personal Care Companies (2024-2032) ($MN)
30 Global Plastic Vials Market Outlook, By Chemical Companies (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
